id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0231-0003,FDA,FDA-2002-N-0231,Agency Information Collection Activities; Announcement of OMB Approval; Focus Groups as Used by the Food and Drug Administration,Notice,Notice of Approval,2002-12-03T05:00:00Z,2002,12,2002-11-26T05:00:00Z,,2025-05-01T19:16:03Z,02-29927,0,0,0900006480497a33
FDA-2002-N-0231-0002,FDA,FDA-2002-N-0231,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Focus Groups as Used by the Food and Drug Administration,Notice,General Notice,2002-09-06T00:00:00Z,2002,9,2002-08-30T04:00:00Z,2002-10-01T03:59:59Z,2025-05-01T18:32:00Z,02-22284,0,0,0900006480497a2c
FDA-2002-N-0231-0001,FDA,FDA-2002-N-0231,FDA,Notice,N-Notice,2002-05-29T04:00:00Z,2002,5,2002-05-29T04:00:00Z,2002-07-24T03:59:59Z,2008-04-12T01:23:07Z,,0,0,09000064804979f8